Live  Work  Play  News & Events    Tech Valley News    Events Calendar    Regional Media    National Recognition    Annual Events  About this Site

Tech Valley News Akrimax Pharmaceuticals Lands New Client Learn more at New company will use Akrimax for pharmaceutical manufacturing Akrimax Pharmaceuticals will manufacture products for Rouses Point Pharmaceuticals LLC, a creation of Akrimax Pharmaceuticals executives Joseph Krivulka and Leonard Mazur. The company will market generic products to chain, wholesale and medical customers across the United States. Rouses Point Pharmaceuticals shipped its first product, Propranolol-ER which is a non-selective beta-blocker used mainly to treat hypertension and a generic form of Inderal. The company says its goal is for $100 million in growth in the next three years. Read More